DTCFF News and Press, Defence Therapeutics Inc Cl A From 04/23/24

Vancouver, British Columbia--(Newsfile Corp. - April 23, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announ...

2024-04-17 04:23:42 ET More on Defence Therapeutics Inc. Financial information for Defence Therapeutics Inc. Read the full article on Seeking Alpha For further details see: Defence Therapeutics signs FMS Consult GmbH for financing strategy

Vancouver, British Columbia--(Newsfile Corp. - April 17, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announ...

Vancouver, British Columbia--(Newsfile Corp. - April 5, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), one of the leading Canadian biotechnology companies working in the field of immune-oncology, announces an amendment to the terms of 1,49...

2024-03-27 17:08:02 ET Stocks to Invest in: Biotech Cancer treatment along with other infectious diseases need clinical solutions and this company may have one. BTV interviews Defense Therapeutics to learn about their proprietary ACCUM™ technology and its proven ability to ...

2024-03-27 17:08:02 ET The treatment of cancer has taken some huge strides forward over the past few decades, but more effective solutions are still urgently needed for a variety of clinical needs. Fortunately, Defence Therapeutics (CSE: DTC, FSE: DTC, OTC: DTCFF) , a Canadian bio...

2024-03-27 17:08:02 ET Investing in healthcare Defence Therapeutics is a Canadian biotech company developing immune-related therapies using their proprietary ACCUM technology. The technology helps bio drugs overcome intracellular barriers, making them more effective. Defence is ex...

Vancouver, British Columbia--(Newsfile Corp. - March 26, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biotechnology company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce t...

Vancouver, British Columbia--(Newsfile Corp. - March 22, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), (" Defence " or the " Company "), one of the leading Canadian biotechnology companies working in the field of immune-oncology, announces the closing of the 2 nd tranch...

Vancouver, British Columbia--(Newsfile Corp. - March 4, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announc...